Neprilysin Inhibitors and Bradykinin by Duncan J. Campbell, Duncan J. Campbell, Duncan J. Campbell

Subjects: Get full text

Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF) by Przemysław Żelazny, Joanna Filipczak, Oliwer Sygacz, Sebastian Bróż, Sara Dankiewicz, Aleksandra Swora, Joanna Borowik, Wojciech Brodowski, Piotr Pawłowski, Katarzyna Basta-Arciszewska

Subjects: Get full text

The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat by Javad Habibi, Annayya R. Aroor, Nitin A. Das, Camila M. Manrique-Acevedo, Megan S. Johnson, Melvin R. Hayden, Ravi Nistala, Charles Wiedmeyer, Bysani Chandrasekar, Vincent G. DeMarco

Subjects: Get full text

The effect of neprilysin and renin inhibition on the renal dysfunction following ischemia‐reperfusion injury in the rat by Fayez T. Hammad, Suhail Al‐Salam, Sarah S. AlZaabi, Maryam M. Alfalasi, Awwab F. Hammad, Javed Yasin, Loay Lubbad

Subjects: Get full text

Sacubitrilat reduces pro‐arrhythmogenic sarcoplasmic reticulum Ca2+ leak in human ventricular cardiomyocytes of patients with end‐stage heart failure by Jörg Eiringhaus, Christoph M. Wünsche, Petros Tirilomis, Jonas Herting, Nadja Bork, Viacheslav O. Nikolaev, Gerd Hasenfuss, Samuel Sossalla, Thomas H. Fischer

Subjects: Get full text

Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review by Domingo Pascual-Figal, Domingo Pascual-Figal, Antoni Bayés-Genis, Antoni Bayés-Genis, Antoni Bayés-Genis, Paola Beltrán-Troncoso, Pedro Caravaca-Pérez, Pedro Caravaca-Pérez, Pedro Caravaca-Pérez, Alicia Conde-Martel, Maria G. Crespo-Leiro, Maria G. Crespo-Leiro, Juan F. Delgado, Juan F. Delgado, Juan F. Delgado, Javier Díez, Javier Díez, Javier Díez, Javier Díez, Francesc Formiga, Nicolás Manito

Subjects: Get full text

Efficacy and safety analysis of angiotensin receptor neprilysin inhibition(ARNI)in patients with heart failure: a real-world retrospective study by Xiaobo Wang, Jun Pu, Guixia Wang, Hui Xu, Liming Liu, Zhen Li, Ruijie Qin, Xuemei Zhao, Ming Li, Zedong Hao, Houxiang Hu

Subjects: “…Angiotensin receptor neprilysin inhibition…”
Get full text

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial by Rolf Wachter, Sanjiv J. Shah, Martin R. Cowie, Peter Szecsödy, Victor Shi, Ghionul Ibram, Ziqiang Zhao, Jianjian Gong, Sven Klebs, Burkert Pieske

Subjects: Get full text

Localization of ^99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses by Aikaterini Kaloudi, Emmanouil Lymperis, Panagiotis Kanellopoulos, Beatrice Waser, Marion de Jong, Eric P. Krenning, Jean Claude Reubi, Berthold A. Nock, Theodosia Maina

Subjects: Get full text

[^99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models by Panagiotis Kanellopoulos, Emmanouil Lymperis, Aikaterini Kaloudi, Marion de Jong, Eric P. Krenning, Berthold A. Nock, Theodosia Maina

Subjects: Get full text